PNPLA3 and metabolic dysfunction-associated steatohepatitis: These patients do not suffer from the metabolic syndrome, nor are they obese, but they do often carry specific genetic polymorphisms that have been associated with an increased propensity for developing NAFLD and NASH, such as PNPLA3 rs738409 [6].